Analyst Emily Bodnar of H.C. Wainwright reiterated a Buy rating on Atossa Therapeutics (ATOS – Research Report), retaining the price target of ...

Atossa Therapeutics (ATOS) announced data describing the discovery of compounds that may be synergistic with (Z)-endoxifen and that could ...

After the rights issue, and as a result of the backstop, the participating creditors hold a 70.6% stake in Atos, ...

Financial and technical problems are fueling concern about whether the bloc can revamp its approach to borders ...

NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN.THIS PRESS RELEASE IS ...

NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN.THIS PRESS RELEASE IS ...

Atos SE (FR:ATO) has released an update. The NTT Group has selected Evidian Identity Governance & Administration from Atos Group to manage ...

Atos and its consortium partners bear a major share of responsibility for delays in deploying the European Union’s delayed biometric border control system.

In accordance with the backstop commitments provided for in the Accelerated Safeguard Plan: Up to 20,270,270,270 New Shares ...

While the original Hyundai Atos enjoyed an extended run in SA, its successor wasn’t here for long. But it's still an ...

Atos SE (OTCMKTS:AEXAF – Get Free Report) saw a large decrease in short interest in November. As of November 15th, there was short interest totalling 149,700 shares, a decrease of 19.1% from the ...

Atos International Paris, France – December 2, 2024 - Atos, a global leader in digital transformation, high-performance computing and information technology infrastructure, today announces that ...